20 Einträge gefunden

1. Return of individual genomic research results within the PRAEGNANT multicenter registry study

   1. Huebner, Hanna
   2. Ruebner, Matthias
   3. Kurbacher, Christian
   4. Hadji, Peyman
   5. Hartkopf, Andreas D
   6. Lux, Michael P
   7. Huober, Jens

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer - Association With Patient and Disease Characteristics and Effect on Prognosis

   1. Fasching, Peter A
   2. Yadav, Siddhartha
   3. Hu, Chunling
   4. Wunderle, Marius
   5. Häberle, Lothar
   6. Hart, Steven N
   7. Rübner, Matthias

   2021 - Forschungsinformationssystem des UKE
5. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
6. Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)

   1. Inwald, Elisabeth C
   2. Albring, Christian
   3. Baum, Erika
   4. Beckermann, Maria
   5. Bühling, Kai J
   6. Emons, Günter
   7. Gudermann, Thomas

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"

   1. Schneeweiss, Andreas
   2. Ettl, Johannes
   3. Lüftner, Diana
   4. Beckmann, Matthias W
   5. Belleville, Erik
   6. Fasching, Peter A
   7. Fehm, Tanja N

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

   1. Laakmann, Elena
   2. Emons, Julius
   3. Taran, Florin-Andrei
   4. Janni, Wolfgang
   5. Uhrig, Sabrina
   6. Overkamp, Friedrich
   7. Kolberg, Hans-Christian

   2020 - Forschungsinformationssystem des UKE
9. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE
10. Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

    1. Schneeweiss, Andreas
    2. Ettl, Johannes
    3. Lüftner, Diana
    4. Beckmann, Matthias W
    5. Belleville, Erik
    6. Fasching, Peter A
    7. Fehm, Tanja N

    2020 - Forschungsinformationssystem des UKE
11. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

    1. Müller, Volkmar
    2. Nabieva, Naiba
    3. Häberle, Lothar
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas D
    6. Volz, Bernhard
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
12. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

    1. Lux, Michael P
    2. Nabieva, Naiba
    3. Hartkopf, Andreas D
    4. Huober, Jens
    5. Volz, Bernhard
    6. Taran, Florin-Andrei
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
13. Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study

    1. Pan, Yiqi
    2. Heisig, Sarah R
    3. von Blanckenburg, Pia
    4. Albert, Ute-Susann
    5. Hadji, Peyman
    6. Rief, Winfried
    7. Nestoriuc, Yvonne

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
14. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

    1. Hartkopf, Andreas D
    2. Huober, Jens
    3. Volz, Bernhard
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Schwitulla, Judith
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
15. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

    1. Taran, Florin-Andrei
    2. Schneeweiss, Andreas
    3. Lux, Michael P
    4. Janni, Wolfgang
    5. Hartkopf, Andreas D
    6. Nabieva, Naiba
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
16. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

    1. Schneeweiss, Andreas
    2. Lux, Michael P
    3. Janni, Wolfgang
    4. Hartkopf, Andreas D
    5. Nabieva, Naiba
    6. Taran, Florin-Andrei
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
17. Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

    1. Wallwiener, Markus
    2. Heindl, Felix
    3. Brucker, Sara Y
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
18. Update Breast Cancer 2017 - Implementation of Novel Therapies

    1. Lux, Michael P
    2. Janni, Wolfgang
    3. Hartkopf, Andreas D
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
19. Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

    1. Hein, Alexander
    2. Gass, Paul
    3. Walter, Christina Barbara
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2016 - Forschungsinformationssystem des UKE
20. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study

    1. Nestoriuc, Yvonne
    2. von Blanckenburg, Pia
    3. Schuricht, Franziska
    4. Barsky, Arthur J.
    5. Hadji, Peyman
    6. Albert, Ute-Susann
    7. Rief, Winfried

    2016 - Forschungsinformationssystem des UKE